Zhenyu Zhang

机构：Ganzhou People's Hospital, The First People’s Hospital of Lianyungang, Nanjing Medical University · ORCID：0000-0002-1523-0672

发表论文 102 篇 · 总被引 1913 次 · h-index 20

代表论文

• Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study (2023 · Journal of Gastroenterology · 被引 38)
• Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial (2024 · The Lancet Microbe · 被引 37)
• Antibiotic resistance of Helicobacter pylori in Nanjing, China: a cross-section study from 2018 to 2023 (2023 · Frontiers in Cellular and Infection Microbiology · 被引 21)
• Simultaneous application of oral and intravaginal probiotics for Helicobacter pylori and its antibiotic-therapy-induced vaginal dysbacteriosis (2024 · npj Biofilms and Microbiomes · 被引 13)
• Ten‐Day Versus 14‐Day Vonoprazan and Amoxicillin Dual Therapy for the Firstline Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial (2025 · Helicobacter · 被引 11)
• Efficacy and safety of tegoprazan (LXI-15028) vs. esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial (2024 · Chinese Medical Journal · 被引 11)